Backgrounds: Growth hormone (GH) was used for many years to increase ovarian response
in poor ovarian responders (PORs). Although meta-analysis suggested that GH therapy …

To investigate whether additional growth hormone (GH) treatment can improve pregnancy
outcomes in poor ovarian responders (POR), this systematic review and meta-analysis is …

Aim The purpose was to explore whether the 6 weeks of growth hormone (GH) pretreatment
could increase the live birth rate of poor ovarian responders (POR). Methods This self …

Purpose The aim of this meta-analysis was to evaluate the effect of growth hormone (GH)
supplementation in poor responders undergoing in vitro fertilization (IVF) or intracytoplasmic …

Growth hormone (GH) is involved in the regulation of male and female infertility. Several
clinical studies reveal that adjuvant GH treatment has a possible role in vitro fertilization …

Background: Growth hormone (GH) is used as an adjuvant therapy in in vitro fertilization and
embryo transfer (IVF-ET) for poor ovarian responders, but findings for its effects on outcomes …

Growth hormone (GH) has a long-standing history of use as an adjunctive therapy in the
treatment of poor ovarian response (POR), but the optimal dosage and timing remains …

BACKGROUND Whether the addition of growth hormone (GH) can improve the probability of
pregnancy in poor responders undergoing ovarian stimulation for in-vitro fertilization (IVF) …

Background: Growth hormone (GH) has long been used as adjuvant treatment in ovarian
stimulation for in vitro fertilization (IVF), especially in poor responder (PR) patients. However …

Objective To evaluate the effectiveness of growth hormone (GH) supplementation in
improving the in vitro fertilization (IVF) outcomes of poor responders. Design Systematic …